RegeneRx Biopharmaceuticals, Inc. Updates Clinical Trials Program (Business Wire via Yahoo! Finance)
BETHESDA, Md.—-RegeneRx Biopharmaceuticals, Inc. , is holding a conference call today at 4:30 p.m. Eastern Time to provide investors with an update on the status of its clinical trials and research and development programs.